Inactief instrument

Koers W WORL

Aandelen

Duur

Periode

Stijl

Pharmos Corp. Designates Eric Fangmann as Acting President and Acting Chief Financial Officer	02-01-13
Pharmos Corp. Announces Management Changes	17-10-12
Pharmos Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2012	30-07-12
Pharmos Corp. Announces Successfully Completion of Proof-Of-Concept Clinical Trial Using its Compound Levotofisopam to Treat Patients with Hyperuricemia and Gout	17-05-12
Pharmos Corp. Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2012	16-04-12

Managers	Titel	Leeftijd	Van
Zhilong Liao CEO	Chief Executive Officer	-	-

W World Corp. is een in de Verenigde Staten gevestigd bedrijf. Het bedrijf heeft geen activiteiten en genereert geen inkomsten.

Sector